110
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Evidence of involvement of the human Par-4 (PAWR) gene in major depressive disorder

, , , , , & show all
Pages 288-295 | Received 27 Mar 2010, Accepted 28 Jun 2010, Published online: 24 Aug 2010

References

  • Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, . 2003. Predisposition locus for major depression at chromosome 12q22–12q23.2. Am J Hum Genet 73:1271–1281.
  • Ainsworth K, Smith SE, Zetterstrom TS, Pei Q, Franklin M, Sharp T. 1998. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berlin) 140:470–477.
  • Anisman H, Irwin J, Sklar LS. 1979a. Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress. Psychopharmacology (Berlin) 64:163–170.
  • Anisman H, Remington G, Sklar LS. 1979b. Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology (Berlin) 61:107–124.
  • Bibb JA. 2005. Decoding dopamine signaling. Cell 122:153–155.
  • Burke WJ, Hendricks SE, McArthur-Campbell D, Jacques D, Stull T. 1996. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing. Psychopharmacol Bull 32:27–32.
  • Cheng AT, Tien AY, Chang CJ, Brugha TS, Cooper JE, Lee CS, . 2001. Cross-cultural implementation of a Chinese version of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) in Taiwan. Br J Psychiatry 178:567–572.
  • Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87–98.
  • Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327–337.
  • Elhwuegi AS. 2004. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435–451.
  • Kapur S, Remington G. 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466–476.
  • Kishi T, Ikeda M, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y, Kawashima K, Ozaki N, Iwata N. 2008. No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 147B:531–534.
  • Klimke A, Larisch R, Janz A, Vosberg H, Müller-Gärtner HW, Gaebel W. 1999. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90:91–101.
  • Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, Hong CJ. 2009. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet Genomics 19:735–741.
  • Mattson MP, Gleichmann M. 2005. The neuronal death protein par-4 mediates dopaminergic synaptic plasticity. Mol Interv 5:278–281.
  • McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, . 2005. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14:3337–3345.
  • Papp M, Klimek V, Willner P. 1994. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berlin) 115:441–446.
  • Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, . 2005. Par-4 links dopamine signaling and depression. Cell 122:275–287.
  • Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522.
  • Sells SF, Wood DP Jr, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, . 1994. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5:457–466.
  • Serretti A, Kato M, Kennedy JL. 2008. Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharmacogenomics J 8:90–100.
  • Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97–105.
  • Sullivan PF. 2007. Spurious genetic associations. Biol Psychiatry 61:1121–1126.
  • Tsai SJ, Liou YJ, Hong CJ, Yu YW, Chen TJ. 2008. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Pharmacogenomics J 8:384–390.
  • Zhao JH. 2004. 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 20:1325–1326.
  • Zhao JH, Lissarrague S, Essioux L, Sham PC. 2002. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 18:1694–1695.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.